CORT
Corcept Therapeutics Inc.
Healthcare •
Biotechnology •
stocks •
XNAS
• usd
$40.13
$-0.57
(-1.40%)
Loading...
SMA 20: -
SMA 50: -
SMA 200: -
| General | Valuation | Profitability | Financial Health | Trading | Ownership |
|---|---|---|---|---|---|
| Market Cap | $4.23B | EPS (ttm) | $0.87 | Current Price | $40.13 |
| Enterprise Value | $3.81B | Forward EPS | $0.73 | Previous Close | $40.70 |
| P/E Ratio | 46.13 | ROA | 5.10% | 52W High | $117.33 |
| Forward P/E | 54.82 | ROE | 16.70% | 52W Low | $32.99 |
| PEG Ratio | - | Gross Margin | 98.19% | 50 Day Avg | $62.13 |
| P/S Ratio | 5.71 | Operating Margin | 4.92% | 200 Day Avg | $70.64 |
| P/B Ratio | 6.68 | Profit Margin | 14.32% | Volume | 1.24M |
| EV/EBITDA | 57.05 | Current Ratio | 3.14 | Avg Volume | 1.83M |
| EV/Sales | 5.13 | Quick Ratio | 2.85 | Beta | 0.26 |
| Employees | 500.00 | Debt/Equity | 1.01 | Shares Outstanding | 105.19M |
| Sector | Healthcare | Total Debt | $6.36M | Float Shares | 86.83M |
| Industry | Biotechnology | Total Cash | $421.68M | Short Float | 10.52% |
| Optionable | - | Cash/Share | $4.01 | Short Ratio | 2.95 |
| Dividend Yield | - | Book Value/Share | $6.01 | % Held by Insiders | 11.63% |
| Target Price | $94.20 | Revenue (TTM) | $741.17M | % Held by Institutions | 74.62% |